Table 4.
Phase 2: Roll-out | Phase 3: Fully-implemented | |
---|---|---|
Total N with a New Depression Diagnosis | 849 | 1,307 |
Women with a Follow-up PHQ-9 | 550 | 1074 |
Follow-up PHQ-9 <10 | 289(52.6%) | 615(57.3%) |
≥50% improvement in symptoms | 294(53.5%) | 602(56.1%) |
Improvement of at least 5 points | 398(72.4%) | 803(74.8%) |